Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rachel Elizabeth Ann, Fincham"'
Publikováno v:
Frontiers in Molecular Biosciences, Vol 9 (2022)
Externí odkaz:
https://doaj.org/article/a9064086960d42d59d0c26a66833aa96
Autor:
Francesca Romana, Delvecchio, Michelle R, Goulart, Rachel Elizabeth Ann, Fincham, Michele, Bombadieri, Hemant M, Kocher
Publikováno v:
World Journal of Gastroenterology. 28:1088-1101
Pancreatic cancer is a disease with high unmet clinical need. Pancreatic cancer is also characterised by an intense fibrotic stroma, which harbours many immune cells. Studies in both human and animal models have demonstrated that the immune system pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63b8eb66d81334105f916b6245cd16ae
https://doi.org/10.3748/wjg.v28.i11.1088
https://doi.org/10.3748/wjg.v28.i11.1088
Autor:
Michelle R Goulart, Konstantinos Stasinos, Rachel Elizabeth Ann Fincham, Francesca R Delvecchio, Hemant M Kocher
Publikováno v:
World Journal of Gastroenterology
Pancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with a dismal 5-year survival rate. PDAC has a complex tumour microenvironment; characterised by a robust desmoplastic stroma, extensive infiltration of immunesuppressive cells s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9b1647caa3685c7ce1ef0833d3a1112
http://europepmc.org/articles/PMC8678814
http://europepmc.org/articles/PMC8678814
Autor:
Kairbaan Hodivala-Dilke, Melania Capasso, Frances R. Balkwill, Hemant M. Kocher, Michele Bombardieri, Sarah Spear, Francesca R. Delvecchio, Andrew Clear, Rachel Elizabeth Ann Fincham, Marina Roy-Luzarraga, John G. Gribben
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology 12(5), 1543-1565 (2021). doi:10.1016/j.jcmgh.2021.06.023
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 5, Pp 1543-1565 (2021)
Cellular and Molecular Gastroenterology and Hepatology 12(5), 1543-1565 (2021). doi:10.1016/j.jcmgh.2021.06.023
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 5, Pp 1543-1565 (2021)
Background and aims The presence of tertiary lymphoid structures (TLSs) may confer survival benefit to patients with pancreatic ductal adenocarcinoma (PDAC), in an otherwise immunologically inert malignancy. Yet, the precise role in PDAC has not been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbca100680dfb1efb8c0cbafa14981d0
http://europepmc.org/articles/PMC8529396
http://europepmc.org/articles/PMC8529396
Autor:
Michelle R. Goulart, Francesca R. Delvecchio, Rachel Elizabeth Ann Fincham, Joe Poe Sheng Yeong, Hemant M. Kocher
Publikováno v:
World Journal of Gastroenterology
Pancreatic cancer remains one of medicine's largest areas of unmet need. With five-year survival rates of < 8%, little improvement has been made in the last 50 years. Typically presenting with advance stage disease, treatment options are limited. To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4f6367f177bc87043edb490e48afafb
https://pubmed.ncbi.nlm.nih.gov/34239264
https://pubmed.ncbi.nlm.nih.gov/34239264